
Bharat Parenterals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-03-05 08:04:40Bharat Parenterals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a strong day change of 5.41%, the stock’s technical indicators present a nuanced picture, with momentum oscillating between mildly bullish and bearish trends. This analysis delves into the recent price momentum, key technical indicators such as MACD, RSI, moving averages, and their implications for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Bharat Parenterals Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-03-04 08:06:38Bharat Parenterals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price declined by 4.60% on 4 Mar 2026, closing at ₹1,090, reflecting growing investor caution amid weakening technical signals and a downgrade in its Mojo Grade to Strong Sell.
Read full news article
Bharat Parenterals Ltd is Rated Strong Sell
2026-02-26 10:10:24Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-02-26 08:02:45Bharat Parenterals Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of late February 2026. Despite a positive day change of 2.26%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses the recent technical developments, price momentum, and comparative returns against the Sensex to provide investors with a comprehensive view of the stock’s current positioning.
Read full news article
Bharat Parenterals Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-02-25 08:03:58Bharat Parenterals Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical parameters suggest caution for investors as the stock's momentum deteriorates.
Read full news article
Bharat Parenterals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-02-24 08:06:06Bharat Parenterals Ltd has exhibited a notable shift in its technical momentum, transitioning from a bearish to a mildly bearish stance as of late February 2026. Despite a robust day change of 4.67%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This analysis delves into the recent price action, technical trends, and comparative performance against the Sensex to provide investors with a comprehensive view of the stock’s current positioning.
Read full news article
Bharat Parenterals Ltd Technical Analysis: Momentum Shifts Amid Bearish Signals
2026-02-23 08:02:59Bharat Parenterals Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a modest day gain of 1.18%, the stock’s overall technical profile has deteriorated, prompting a downgrade in its Mojo Grade to Strong Sell as of 29 Sep 2025. This article analyses the recent technical parameter changes, price momentum, and what these signals imply for investors navigating the current market environment.
Read full news article
Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-02-20 08:04:16Bharat Parenterals Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish trend, reflecting a nuanced change in investor sentiment. Despite a day gain of 2.84%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious optimism amid underlying challenges.
Read full news article
Bharat Parenterals Ltd is Rated Strong Sell
2026-02-15 10:10:19Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
11-Feb-2026 | Source : BSEPlease find the enclosed newspaper notice to physical shareholders informing them about the special window to re-lodge the transfer deed.
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-Jan-2026 | Source : BSEcopy of newspaper advertisement for the unaudited financial results for the quarter and nine months ended December 31 2025.
Financial Results For The Quarter And Nine Months Ended On December 31 2025.
30-Jan-2026 | Source : BSEUnaudited Financial Results for the Quarter and Nine Months Ended on December 31 2025.
Corporate Actions
No Upcoming Board Meetings
Bharat Parenterals Ltd has declared 10% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available






